Churchill Capital Corp VII

Churchill Capital Corp. VII operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization, or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on October9, 2020 and is headquartered in New York, NY.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Churchill Capital Corp. VII is a blank check company, which engages in the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization, or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on October 09, 2020 and is headquartered in New York, NY.

Board of Directors Recommends Stockholders and Warrant Holders Vote "FOR" All Proposals NEW YORK and ALTRINCHAM, England , March 22, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it has scheduled a special meeting of Churchill VII stockholders and a meeting of Churchill VII warrant holders for May 21, 2024 in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill VII (the "Business Combination"). The Business Combination continues to progress and is expected to be completed in the first half of 2024.

Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Warrant Holder Meeting to Approve Warrant Amendment Scheduled for May 21, 2024

In Excess of $605 Million Remains in Churchill VII's Trust Account after Stockholder Redemptions relating to the Extension NEW YORK , Feb. 12, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NASDAQ: CVII) announced today that in a special meeting of its stockholders ("Special Meeting"), Churchill VII's stockholders voted to approve a proposal to amend Churchill VII's certificate of incorporation and extend the date by which Churchill VII is required to consummate its initial business combination (the "Business Combination") with CorpAcq Holdings Limited ("CorpAcq") from February 17, 2024 to August 17, 2024 (or such earlier date as determined by the board of directors of Churchill VII). All other proposals were also approved with overwhelming support from Churchill VII's stockholders.

Churchill Capital Corp VII Announces Stockholder Approval of Extension and Final Redemption Numbers

Special meeting of stockholders of Churchill VII scheduled for February 8, 2024 to extend date by which Churchill VII must consummate its business combination with CorpAcq Holdings Limited NEW YORK , Jan. 30, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") announced today actions being undertaken in advance of a special meeting of its stockholders (the "Special Meeting") on February 8, 2024, at which Churchill VII's stockholders will be asked to vote on, among other things, a proposal to amend Churchill VII's amended and restated certificate of incorporation to extend the date by which Churchill VII has to consummate its business combination with CorpAcq Holdings Limited ("CorpAcq") from February 17, 2024 to August 17, 2024 or such earlier date as determined by the Churchill VII board of directors (the "Board") (the "Extension Amendment Proposal"). Churchill VII Sponsor Seeking Extension to Pursue a Business Combination with CorpAcq Holdings Limited As previously disclosed, on August 1, 2023, Churchill VII entered into a definitive agreement for a business combination (and together with the transactions contemplated thereby, the "Transactions") with CorpAcq, a corporate compounder with a proven track record of acquiring and supporting founder-led businesses.

Churchill Capital Corp VII Announces Continuation of $1,000,000 Monthly Sponsor Contribution

NEW YORK , Jan. 23, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NYSE: CVII), a special purpose acquisition company, announced today that it plans to transfer the listing of its shares of Class A common stock, public warrants and public units from the New York Stock Exchange ("NYSE") to Nasdaq Global Market ("Nasdaq"). Churchill VII expects that listing and trading of its securities on the NYSE will end at market close on February 2, 2024, and expects to commence trading as a Nasdaq-listed company upon market open on February 5, 2024.

Churchill Capital Corp VII Announces Intention to Transfer Listing to Nasdaq

ALTRINCHAM, England and NEW YORK , Jan. 22, 2024 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, today provided the following business update including: Reaffirming guidance for the full year ending December 31, 2023; Confirming on track timing of its Business Combination with Churchill Capital Corp VII ("Churchill VII") (NYSE: CVII); A successful refinancing of its group debt; and Upcoming Analyst Day.  Management Reaffirms Financial Outlook for Full-Year 2023  Since the release of its financials for the first six months of 2023 on November 17, 2023, CorpAcq has continued to maintain its strong and profitable growth trajectory.

CorpAcq Reaffirms 2023 Guidance and Provides Business and Refinancing Update

ALTRINCHAM, England and NEW YORK , Nov. 17, 2023 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, Churchill Capital Corp VII ("Churchill VII") (NYSE: CVII), a special purpose acquisition company, and CorpAcq Group Plc, a public limited company incorporated under the laws of England and Wales ("CorpAcq Group"), announced today the filing of a registration statement of CorpAcq Group on Form F-4 (the "Registration Statement") with the U.S. Securities and Exchange Commission (the "SEC") on November 17, 2023. The Registration Statement contains a proxy statement/prospectus in connection with the definitive agreement entered into between Churchill VII, CorpAcq and CorpAcq Group with respect to the proposed business combination (the "Merger Agreement", and the transactions contemplated thereby, the "Transactions").

CorpAcq and Churchill Capital Corp VII Announce Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination and CorpAcq's First Half 2023 Results

CorpAcq is a corporate compounder and preferred acquirer of founder-led small and medium-sized enterprises in the UK anchored by a diversified portfolio of 41 stable and profitable businesses Transaction is expected to provide CorpAcq with capital to optimize its balance sheet and the opportunity to fund accelerated growth and scale with a broader acquisition pipeline CorpAcq has grown revenue at an annual rate of 16% and adjusted EBITDA 1  of 17% over the last 4 years including average organic revenue growth of 4% and subsidiary-level profit growth of 7%, respectively Transaction implies an initial enterprise value of approximately $1.58 billion, providing an attractive entry point for Churchill VII's shareholders at approximately 10x current year adjusted EBITDA CorpAcq intends to initiate a dividend policy from closing targeting an attractive dividend yield that will be supported by free cash flow from current operations ALTRINCHAM, England and NEW YORK , Aug. 1, 2023 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill Capital Corp VII ("Churchill VII") (NYSE: CVII), a special purpose acquisition company, announced today that they have entered into a definitive agreement for a business combination (the "transaction"). The transaction values CorpAcq at a pro forma enterprise value of approximately $1.58 billion and is expected to provide CorpAcq with up to $592 million in the cash held in Churchill VII's trust account (assuming no redemptions), which will help facilitate advancing CorpAcq's strategy and accelerating its growth initiatives.

CorpAcq to Go Public via Business Combination with Churchill Capital Corp VII

News for Churchill Capital Corp VII Stock (CVII)